| Identification | Back Directory | [Name]
1-butylbiguanide | [CAS]
692-13-7 | [Synonyms]
DBV
W 37
H 224
Buformin
Glybigid
Buformine
Butformin
Dibetos B
Butylbiguanide
Butyldiguanide
1-butylbiguanide
N1-Butylbiguanide
N-BUTYLBIGUANIDINE
N-Butyl-idodicarbonimidic Diamide
2-butyl-1-(diaminomethylene)guanidine
2-butyl-1-(diaminomethylidene)guanidine
Buformin (base and/or unspecified salts)
1-[bis(azanyl)methylidene]-2-butyl-guanidine | [EINECS(EC#)]
211-726-4 | [Molecular Formula]
C6H15N5 | [MDL Number]
MFCD00242653 | [MOL File]
692-13-7.mol | [Molecular Weight]
157.217 |
| Hazard Information | Back Directory | [Uses]
Buformin, clinically used for diabetes mellitus, is known to improve resistance to insulin in patients. It suppresses the expression of glyceraldehyde 3-phosphate dehydrogenase | [Definition]
ChEBI: Buformin is a member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect. It has a role as a hypoglycemic agent, a geroprotector, a radiosensitizing agent, an antineoplastic agent and an antiviral agent. It is functionally related to a biguanide. | [Brand name]
Adebit;Andebit;Andelit;Andere;Biforon;Bigunal;Biquinal;Bs-5892;Bufonamin;Bulbonin;Diabrin;Dutformin;Gliporal;Insulamin;Krebon;Panformin;Silubin retard;Sindiatil;Tidemol retard;Ziavetine. | [World Health Organization (WHO)]
Buformin is an analogue of phenformin. See WHO comment for
phenformin.
(Reference: (WHODI) WHO Drug Information, 2, 4, 1977) |
|
| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Website: |
www.lgmpharma.com |
| Company Name: |
InvivoChem
|
| Tel: |
13549236410 |
| Website: |
https://www.invivochem.cn/ |
|